Interdisciplinary S2 guideline: Diagnosis and treatment of venous thrombosis of the legs and the pelvis and of pulmonary embolism;Interdisziplinäre S2-Leitlinie: Diagnostik und therapie der bein- und beckenvenenthrombose und der lungenembolie

Phlebologie

Volumn 34, Issue 1, 2005, Pages 47-64

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CERTOPARIN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; FRAXIFORTE; HEPARIN; MONO EMBOLEX THERAPIE; NADROPARIN; PENTASACCHARIDE; THROMBIN INHIBITOR; TINZAPARIN; UNCLASSIFIED DRUG; XIMELAGATRAN;

COMPUTER ASSISTED TOMOGRAPHY; D DIMER TEST; DIAGNOSTIC TEST; ECHOGRAPHY; HUMAN; LEG THROMBOSIS; LUNG EMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PHLEBOGRAPHY; PRACTICE GUIDELINE; REVIEW; VEIN THROMBOSIS;

EID: 14944346282     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621471     Document Type: Review

References (135)

1. Anderson DR, Kovacs MJ, Kovacs G et al. Combined use of clinical assessment and D-dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study). Thromb Haemost 2003; 1: 645-51.
2. Arcasoy SM, Vachani A. Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med 2003; 24: 73-91.
3. Arzneimittelkommission der deutschen Ärzteschaft. Bekanntgabe zur Heparin-induzierten Thrombozytopenie. Dt Ärzteblatt 1999; 96 (Heft 6).
4. Aschwanden M, Labs KH, Engel H et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 2001; 85: 42-6.
5. Baglin T, Luddington R, Brown K et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-6.
6. Baldwin ZK, Comerota AJ, Schwartz LB. Catheter-directed thrombolysis for deep venous thrombosis. Vasc Endovascular Surg 2004; 38: 1-9.
7. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. Lancet 1960;: 1309-12.
8. Bates SM, Kearon C, Crowther M, et al. A Diagnostic Strategy Involving a Quantitative Latex D-Dimer Assay Reliably Excludes Deep Venous Thrombosis. Ann Intern Med 2003; 138: 787-94.
9. Beer JH, Burger M, Gretener S et al. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost 2003; 1: 186-7.
10. Bernardi E, Prandoni P, Lensing AWA et al. D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study. Br Med J 1998; 317: 1037-40.
11. Bertina RM. Molecular risk factors for thrombosis. Thromb Haemost 1999; 82: 601-9.
12. Blättler W, Heller G, Largiadèr J et al. Combined regional thrombolysis and surgical thrombectomy for treatment of iliofemoral vein thrombosis. J Vasc Surg 2004; 40: 620-5.
13. Blättler W, Martinez I, Blättler IK. Diagnosis of deep venous thrombosis and alternative diseases in symptomatic outpatients. Eur J Intern Med 2004; 15: 305-11.
14. Blevins S, Edwards S, Raskob G. Helical computed tomography and magnet resonance imaging: diagnosis of pulmonary embolism in symptomatic patients. Curr Opin Hematol 2003; 10: 345-50.
15. Brandjes DPM, Büller HR, Heijboer H et al. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-62.
16. Brill-Edwards P, Ginsberg JS, Gent M et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med 2000; 343: 1439-44.
17. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society Guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470-84.
18. Büller HR, Agnelli G, Hull RD et al. Anti-thrombotic therapy for venous thromboembolic disease. The Seventh ADDP Conference on Antithrombotic and Thrombotic Therapy. Chest 2004; 126: 401S-28.
19. Büller HR, Davidson BL, Decousus H et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. Ann Intern Med 2004; 140: 867-73.
20. Büller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 348: 1695-702.
21. Büller HR, Prins MH. Secondary prophylaxis with warfarin for venous thromboembolism. N Engl J Med 2003; 349: 702-4.
22. Bundesärztekammer. Richtlinienerfassung zur Krebsfrüherkennung. Änderungsbeschluss vom 04.10.2002. Dt Ärzteblatt 2002; 99: A 706-8.
23. Cogo A, Lensing AWA, Koopman MMW et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. Br Med J 1998; 316: 17-20.
24. Cornuz J, Ghali WA, Hayoz D et al. Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D-dimer testing. Am J Med 2002; 112: 198-203.
25. Cueto SM, Cavanaugh SH, Benenson RS et al. Computed tomography scan versus ventilation-perfusion lung scan in the detection of pulmonary embolism. J Emerg Med 2001; 21: 155-64.
26. Dalen JE, Alpert JS, Hirsh J. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med 1997; 157: 2550-6.
27. Decousus H, Epinat M, Guillot K et al. A: Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Pulm Med 2003; 9: 393-7.
28. Decousus H, Leizorovicz A, Parent F et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338: 409-15.
29. DGA. Leitlinien zur Diagnostik und Therapie der Venenthrombose und Lungenembolie. VASA 2002; 31: Suppl 60.
30. DGP. Leitlinie zur Diagnostik und Therapie der tiefen Bein- und Beckenvenenthrombose. Phlebologie 2003; 6: 157-64.
31. Eklof B, Arfvidsson B, Kistner RL et al. A: Indications for surgical treatment of iliofemoral vein thrombosis. Hematol Oncol Clin North Am 2000; 14: 471-82.
32. Elias A, Mallard L, Elias M et al. A single complete ultrasound investigation of the venous network for the diagnostic management of patient with a clinically suspected first episode of deep venous thrombosis of the lower limbs. Thromb Haemost 2003; 89: 221-7.
33. Eriksson H, Wahlander K, Gustafsson D et al. A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I. J Thromb Haemost 2003; 1: 41-7.
34. Fattorini A, Crippa L, Vigano D'Angelo S et al. Risk of deep vein thrombosis recurrence: high negative predictive value of D-dimer performed during oral anticoagulation. Thromb Haemost 2002; 88: 162-3.
35. Gerhardt A, Scharf RE, Beckmann MW et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-80.
36. Gerlach HE, Blättler W. Kontrollierte Einführung der ambulanten Behandlung der akuten tiefen Beinvenenthrombose: Machbarkeitsstudie an 827 Patienten. Phlebologie 2002; 31: 77-84.
37. Ghaye B, Szapiro D, Mastora I et al. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 2001; 219: 629-36.
38. Giannitsis E, Muller-Bardorff M, Kurowski V et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-7.
39. Ginsberg JS, Bates SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost 2003; 1: 1435-42.
40. Goldhaber SZ. A clinical overview of venous thromboembolism. Vasc Med 1998; 3: 35-40.
41. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339: 93-104.
42. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002; 136: 691-700.
43. Gottlieb RH, Voci SL, Syed L et al. Randomized prospective study comparing routine versus selective use of sonography of the complete calf in patients with suspected deep venous thrombosis. Am J Roentgenol 2003; 180: 241-5.
44. Grifoni S, Olivotto I, Cecchini P et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817-22.
45. Gulba DC, Schmid C, Borst HG et al. Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994; 343: 576-7.
46. Hach W, Hach-Wunderle V. Phlebography and sonography of the veins. Berlin, Heidelberg: Springer 1997:
47. Hach W, Hach-Wunderle V. Die phlebographische Untersuchung der Soleus- und Gastrocnemiusvenen. Gefäßchirurgie 2002; 7: 31-8.
48. Hach W, Hach-Wunderle V, Präve F. Wie lassen sich die Phlebogramme verbessern? Gefäßchirurgie 2003; 8: 55-62.
49. Heilmann L, Rath W, von Tempelhoff GF et al. Niedermolekulare Heparine in der Schwangerschaft. Dt Ärzteblatt 2002; 99: A424-32.
50. Hirsh J, Dalen JE, Anderson DR et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S-21.
51. Hull R, Hirsh J, Sackett DL et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 1981; 64: 622-5.
52. Hull RD, Raskob GE, Brant RF et al. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Arch Intern Med 1997; 157: 2317-21.
53. Hutten BA, Prins MH. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism (Cochrane Review). The Cochrane Library 2004; issue 4.
54. Iorio A, Guercini F, Fini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 2002; 1: 1906-13.
55. Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg 2000; 37: 165-252.
56. Kanne JP, Lanani TA. Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism. Circulation 2004; 109: I15-21.
57. Kasper W, Geibel A, Tiede N et al. Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography. Br Heart J 1993: 70: 352-6.
58. Kasper W, Konstantinides S, Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-71.
59. Kasper W, Konstantinides S, Geibel A et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77: 346-9.
60. Katz DS, Loud PA, Bruce D et al. Combined CT venography and pulmonary angiography: a comprehensive review. Radiographics 2002; 22: 3-24.
61. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: 122-30.
62. Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-7.
63. Konstantinides S, Geibe A, Olschewski M et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-8.
64. Koopman MMW, Prandoni P, Piovella F et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334; 682-7.
65. Kruip MJHA, Leclercq MGL, van der Heul C et al. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. Ann Intern Med 2003; 138: 941-51.
66. Kucher N, Printzen G, Doernhoefer T et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003; 107: 1576-8.
67. Kurkciyan II, Sterz F, Meron G et al. Thrombolysis and pulmonary embolism presenting with cardiac arrest. Arch Intern Med 2000; 160: 3496-7.
68. Largiadèr J, Blättler W, Gloor B. Therapeutic concept for acute leg and pelvic venous thrombosis. Acta Chir Belg 2002; 102: 356-61.
69. Lee AYY, Levine MN, Baker RI et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
70. Lensing AW, Prins MH, Falanga A et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2004; 2: 884-9.
71. Levine M, Gent M, Hirsh J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-81.
72. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-82.
73. Mayer E, Dahm M, Hake U et al. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 1996; 61: 1788-92.
74. Meyer G, Marjanovic Z, Valcke J et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 2002; 162: 1729-35.
75. Middeldorp S, Meinardi JR, Koopman MMW et al. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 2001; 135: 322-7.
76. Mills TD, Chan O, Matson M. The use of vena caval filters. Hosp Med 2001; 62: 327-31.
77. Miniati M, Prediletto R, Formichi B et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 1999; 159; 864-71.
78. Monreal M, Lensing AW, Prins MH et al. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2004; 2: 876-81.
79. Moser KM, Daily PO, Peterson K et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients. Ann Intern Med 1987; 107: 560-5.
80. Mousa SA, Mohamed S. Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy. Oncol Rep 2004; 12: 683-8.
81. Musset D, Parent F, Meyer G et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360: 1914-20.
82. Nettelbladt E, Wuppermann T. Klinische Untersuchungen der tiefen Beinvenenthrombose. In: Wuppermann T, Richter A (Hrsg). Thrombose und Thrombosefolgen. Konstanz: Schnetztor 1991:
83. Nilsson T, Mare K, Carlsson A. Value of structured clinical and scintigraphic protocols in acute pulmonary embolism. J Intern Med 2001; 250: 213-8.
84. O'Meara Jr, McNutt RA, Evans AT et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330: 1895-6.
85. Palareti G, Legnani C, Cosmi B et al. Risk of venous thromboembolism recurrence: high negative value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002; 87: 7-12.
86. Partsch H, Blättler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000; 32: 861-9.
87. Pengo V, Lensing AW, Prins MH et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-64.
88. Perkins JM, Magee TR, Galland RB. Phlegmasia caerulea dolens and venous gangrene. Br J Surg 1996; 83: 19-23.
89. Perrier A, Desmarais S, Miron J et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-5.
90. Perrier A, Howarth N, Didier D et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001; 135: 88-97.
91. Perrier A, Roy PM, Aujesky D et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004; 116: 291-9.
92. Pillny M, Sandmann W, Luther B et al. Deep venous thrombosis during pregnancy and after delivery: indications for and results of thrombectomy. J Vasc Surg 2003; 37: 528-32.
93. Pinede L, Duhaut P, Cucherat M et al. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials. J Intern Med 2000; 247: 553-62.
94. Plate G, Eklof B, Norgren L et al. Venous thrombectomy for iliofemoral vein thrombosis: 10-year results of a prospective randomised study. Eur J Vasc Endovasc Surg 1997; 14: 367-74.
95. Prandoni P, Lensing AW, Bernardi E et al. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 2002; 88:402-6.
96. Prandoni P, Lensing AW, Prins MH et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141: 249-56.
97. Prins MH, Hutten BA, Koopman MMW et al. Long-term treatment of venous thromboembolic disease. Thromb Haemost 1999; 82: 892-8.
98. Prologo JD, Glauser J. Variable diagnostic approach to suspected pulmonary embolism in the ED of a major academic tertiary care center. Am J Emerg Med 2002; 20: 5-9.
99. Pruszczyk P, Kostrubiec M, Bochowicz A et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003; 22: 649-53.
100. Raptopoulos V, Boiselle PM. Multi-detector row spiral CT pulmonary angiography: comparison with single-detector row spiral CT. Radiology 2001; 221: 606-13.
101. Rath W, Heilmann L. Thrombophile Risikofaktoren und Schwangerschaftskomplikationen. Frauenarzt 2002; 43: 537-46.
102. Reekers JA, Baarslag HJ, Koolen MG et al. Mechanical thrombectomy for early treatment of massive pulmonary embolism. Cardiovasc Intervent Radiol 2003; 26: 246-50.
103. Reissig A, Kroegel C. Therapeutic approaches to acute pulmonary embolism. Internist 2004; 45: 540-8.
104. Ridker PM, Goldhaber SZ, Danielson E et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348: 1425-34.
105. Schellong SM, Schwarz T, Halbritter K et al. Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost 2003; 89: 228-34.
106. Schellong SM, Schwarz T, Kropp J et al. Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism. Thromb Haemost 1999; 82: 127-9.
107. Schoepf UJ, Holzknecht N, Helmberger TK et al. Subsegmental pulmonary emboli: improved detection with thin-collimation multidetector row spiral CT. Radiology 2002; 222: 483-90.
108. Schulman S, Wählander K, Lundström T et al. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 2003; 349: 1713-21.
109. Schutgens REG, Ackermark P, Haas FJLM et al. Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation 2003; 107: 593-7.
110. Schwarz T, Romahn K, Schellong SM. The value of compression ultrasound of the calf veins in patients with acute pulmonary embolism. Haemostaseologie 2004; 24: A63.
111. Schwarz T, Schmidt B, Höhlein U et al. Eligibility for home treatment of deep vein thrombosis: prospective study. Br Med J 2001: 322: 1212-3.
112. Simmoneau G, Sors H, Charbonnier B. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-9.
113. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 978-81.
114. Stein PD, Hull RD, Patel KD et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism. Ann Intern Med 2004; 140: 589-602.
115. Tack D, De Maertelaer V, Gevenois PA. Dose reduction in multidetector CT using attenuation-based online tube current modulation. Am J Roentgenol 2003; 181: 331-4.
116. Tapson VF, Witty LA. Massive pulmonary embolism. Diagnostic and therapeutic strategies. Clin Chest Med 1995; 16: 329-40.
117. The PIOPED Investigators. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the prospective study of acute pulmonary diagnosis. Am J Respir Crit Care Med 1996; 154: 1387-93.
118. Tutschek B, Struve S, Goecke T et al. Clinical risk factors for deep venous thrombosis in pregnancy and the puerperium. J Perinat Med 2002; 30: 367-70.
119. van Seek EJ, Brouwers EM, Song B et al. Lung scintigraphy and helical computed tomography for the diagnosis of pulmonary embolism: a meta-analysis. Clin Appl Thromb Hemost 2001; 7: 87-92.
120. van den Belt AG, Prins MH, Lensing AW et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2000; CD001100.
121. van der Heijden JF, Hutten BA, Büller HR et al. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev 2000; 4: CD002001 2002.
122. van Dongen CJ, Vink R, Hutten BA et al. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Arch Intern Med 2003; 163: 1285-93.
123. Vieillard-Baron A, Qanadli SD, Antakly Y et al. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures. Intensive Care Med 1998; 24: 429-33.
124. Wacker P, Wacker R, Kreft H-U et al. Akute Lungenembolie: Die meisten Patienten weisen für die Diagnosestellung charakteristische Symptome auf. Ein Algorithmus für die Krankenhausnotaufnahme bzw. den Patient-Arzt-Primärkontakt wird vorgeschlagen. Intensivmed 2004; 41: 283.
125. Wacker P, Wacker R, Kreft HU et al. Akute Lungenembolie: Der echokardiographische Rechtsherz-Score ist nicht nur Prädiktor der Krankenhaussterblichkeit, sondern auch Prädiktor der 6-Monats- Sterblichkeit. Intensivmed 2004; 41: 270.
126. Warkentin TE. Heparin-induced thrombocytopenia: yet another treatment paradox? Thromb Haemost 2001; 85: 947-9.
127. Wells PS, Anderson DR, Bormanis J et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795-8.
128. Wells PS, Anderson DR, Rodger M et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-35.
129. Wells PS, Forster AJ. Thrombolysis in deep vein thrombosis: is there still an indication? Thromb Haemost 2001; 86: 499-508.
130. Wells PS, Ginsberg JS, Andersen DR et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129: 997-1005.
131. Wells PS, Hirsh J, Anderson DR et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326-30.
132. Wells PS, Rodger M. Diagnosis of pulmonary embolism: when is imaging needed? Clin Chest Med 2003; 24: 13-28.
133. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: 1-8.
134. Wicki J, Perneger TV, Junod AF et al. Assessing clinical probability of pulmonary embolism in the emergency ward. Arch Intern Med 2001; 161: 92-7.
135. Wildberger JE, Mahnken AH, Schmitz-Rode T et al. Individually adapted examination protocols for reduction of radiation exposure in chest CT. Invest Radiol 2001; 36: 604-11.